News
In line with MIT and Recursion’s commitment to making AI tools accessible for drug developers, Boltz-2 will be open-sourced under an MIT license, making the model, weights, and training pipeline ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback